 | • レポートコード：MRC2-11QY12647 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はメンデル法則検査のグローバル市場について調査・分析したレポートです。種類別（保因者検査、診断検査、新生児スクリーニング、予測・発症前検査、出生前検査）市場規模、用途別（病院、外来手術センター、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メンデル法則検査の競争状況、市場シェア ・世界のメンデル法則検査市場：種類別市場規模 2015年-2020年（保因者検査、診断検査、新生児スクリーニング、予測・発症前検査、出生前検査） ・世界のメンデル法則検査市場：種類別市場規模予測 2021年-2026年（保因者検査、診断検査、新生児スクリーニング、予測・発症前検査、出生前検査） ・世界のメンデル法則検査市場：用途別市場規模 2015年-2020年（病院、外来手術センター、専門クリニック） ・世界のメンデル法則検査市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、専門クリニック） ・北米のメンデル法則検査市場分析：米国、カナダ ・ヨーロッパのメンデル法則検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメンデル法則検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメンデル法則検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメンデル法則検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Celera Group、Abbott Laboratories、ELITech Group、Quest Diagnostics、AutoGenomics、PerkinElmer、Roche Diagnostics、Bio-Rad Laboratories、Applied Biosystems、Transgenomic ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The Mendelian disorder is different types of genetic disorder in humans. These genetic disorders are mainly caused by the changes or alterations in a single gene or due to the abnormalities in the genome. These conditions will be present since the child’s birth and can be predicted based on the history of a family with the help of a family tree. This process of analysis is called the pedigree analysis.
The different types of Mendelian disorders can be easily determined from the pedigree analysis. Few examples of the Mendelian disorder in humans are Sickle cell anemia, color blindness, muscular dystrophy, Thalassemia, cystic fibrosis, skeletal dysplasia, hemophilia, and phenylketonuria are the most common Mendelian disorders.
Market Analysis and Insights: Global Mendelian Disorders Testing Market
The global Mendelian Disorders Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Mendelian Disorders Testing Scope and Market Size
Mendelian Disorders Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mendelian Disorders Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Celera Group
Abbott Laboratories
ELITech Group
Quest Diagnostics
AutoGenomics
PerkinElmer
Roche Diagnostics
Bio-Rad Laboratories
Applied Biosystems
Transgenomic
Market segment by Type, the product can be split into
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mendelian Disorders Testing Revenue
1.4 Market by Type
1.4.1 Global Mendelian Disorders Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Carrier Testing
1.4.3 Diagnostic Testing
1.4.4 New-Born Screening
1.4.5 Predictive & Pre-Symptomatic Testing
1.4.6 Prenatal Testing
1.5 Market by Application
1.5.1 Global Mendelian Disorders Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialized Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mendelian Disorders Testing Market Perspective (2015-2026)
2.2 Global Mendelian Disorders Testing Growth Trends by Regions
2.2.1 Mendelian Disorders Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mendelian Disorders Testing Historic Market Share by Regions (2015-2020)
2.2.3 Mendelian Disorders Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mendelian Disorders Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Mendelian Disorders Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mendelian Disorders Testing Players by Market Size
3.1.1 Global Top Mendelian Disorders Testing Players by Revenue (2015-2020)
3.1.2 Global Mendelian Disorders Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Mendelian Disorders Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mendelian Disorders Testing Market Concentration Ratio
3.2.1 Global Mendelian Disorders Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mendelian Disorders Testing Revenue in 2019
3.3 Mendelian Disorders Testing Key Players Head office and Area Served
3.4 Key Players Mendelian Disorders Testing Product Solution and Service
3.5 Date of Enter into Mendelian Disorders Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mendelian Disorders Testing Historic Market Size by Type (2015-2020)
4.2 Global Mendelian Disorders Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mendelian Disorders Testing Market Size by Application (2015-2020)
5.2 Global Mendelian Disorders Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mendelian Disorders Testing Market Size (2015-2020)
6.2 Mendelian Disorders Testing Key Players in North America (2019-2020)
6.3 North America Mendelian Disorders Testing Market Size by Type (2015-2020)
6.4 North America Mendelian Disorders Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mendelian Disorders Testing Market Size (2015-2020)
7.2 Mendelian Disorders Testing Key Players in Europe (2019-2020)
7.3 Europe Mendelian Disorders Testing Market Size by Type (2015-2020)
7.4 Europe Mendelian Disorders Testing Market Size by Application (2015-2020)
8 China
8.1 China Mendelian Disorders Testing Market Size (2015-2020)
8.2 Mendelian Disorders Testing Key Players in China (2019-2020)
8.3 China Mendelian Disorders Testing Market Size by Type (2015-2020)
8.4 China Mendelian Disorders Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mendelian Disorders Testing Market Size (2015-2020)
9.2 Mendelian Disorders Testing Key Players in Japan (2019-2020)
9.3 Japan Mendelian Disorders Testing Market Size by Type (2015-2020)
9.4 Japan Mendelian Disorders Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mendelian Disorders Testing Market Size (2015-2020)
10.2 Mendelian Disorders Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mendelian Disorders Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Mendelian Disorders Testing Market Size by Application (2015-2020)
11 India
11.1 India Mendelian Disorders Testing Market Size (2015-2020)
11.2 Mendelian Disorders Testing Key Players in India (2019-2020)
11.3 India Mendelian Disorders Testing Market Size by Type (2015-2020)
11.4 India Mendelian Disorders Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mendelian Disorders Testing Market Size (2015-2020)
12.2 Mendelian Disorders Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Mendelian Disorders Testing Market Size by Type (2015-2020)
12.4 Central & South America Mendelian Disorders Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Celera Group
13.1.1 Celera Group Company Details
13.1.2 Celera Group Business Overview
13.1.3 Celera Group Mendelian Disorders Testing Introduction
13.1.4 Celera Group Revenue in Mendelian Disorders Testing Business (2015-2020))
13.1.5 Celera Group Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Mendelian Disorders Testing Introduction
13.2.4 Abbott Laboratories Revenue in Mendelian Disorders Testing Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 ELITech Group
13.3.1 ELITech Group Company Details
13.3.2 ELITech Group Business Overview
13.3.3 ELITech Group Mendelian Disorders Testing Introduction
13.3.4 ELITech Group Revenue in Mendelian Disorders Testing Business (2015-2020)
13.3.5 ELITech Group Recent Development
13.4 Quest Diagnostics
13.4.1 Quest Diagnostics Company Details
13.4.2 Quest Diagnostics Business Overview
13.4.3 Quest Diagnostics Mendelian Disorders Testing Introduction
13.4.4 Quest Diagnostics Revenue in Mendelian Disorders Testing Business (2015-2020)
13.4.5 Quest Diagnostics Recent Development
13.5 AutoGenomics
13.5.1 AutoGenomics Company Details
13.5.2 AutoGenomics Business Overview
13.5.3 AutoGenomics Mendelian Disorders Testing Introduction
13.5.4 AutoGenomics Revenue in Mendelian Disorders Testing Business (2015-2020)
13.5.5 AutoGenomics Recent Development
13.6 PerkinElmer
13.6.1 PerkinElmer Company Details
13.6.2 PerkinElmer Business Overview
13.6.3 PerkinElmer Mendelian Disorders Testing Introduction
13.6.4 PerkinElmer Revenue in Mendelian Disorders Testing Business (2015-2020)
13.6.5 PerkinElmer Recent Development
13.7 Roche Diagnostics
13.7.1 Roche Diagnostics Company Details
13.7.2 Roche Diagnostics Business Overview
13.7.3 Roche Diagnostics Mendelian Disorders Testing Introduction
13.7.4 Roche Diagnostics Revenue in Mendelian Disorders Testing Business (2015-2020)
13.7.5 Roche Diagnostics Recent Development
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Details
13.8.2 Bio-Rad Laboratories Business Overview
13.8.3 Bio-Rad Laboratories Mendelian Disorders Testing Introduction
13.8.4 Bio-Rad Laboratories Revenue in Mendelian Disorders Testing Business (2015-2020)
13.8.5 Bio-Rad Laboratories Recent Development
13.9 Applied Biosystems
13.9.1 Applied Biosystems Company Details
13.9.2 Applied Biosystems Business Overview
13.9.3 Applied Biosystems Mendelian Disorders Testing Introduction
13.9.4 Applied Biosystems Revenue in Mendelian Disorders Testing Business (2015-2020)
13.9.5 Applied Biosystems Recent Development
13.10 Transgenomic
13.10.1 Transgenomic Company Details
13.10.2 Transgenomic Business Overview
13.10.3 Transgenomic Mendelian Disorders Testing Introduction
13.10.4 Transgenomic Revenue in Mendelian Disorders Testing Business (2015-2020)
13.10.5 Transgenomic Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Mendelian Disorders Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Mendelian Disorders Testing Revenue
Table 3. Ranking of Global Top Mendelian Disorders Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mendelian Disorders Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Carrier Testing
Table 6. Key Players of Diagnostic Testing
Table 7. Key Players of New-Born Screening
Table 8. Key Players of Predictive & Pre-Symptomatic Testing
Table 9. Key Players of Prenatal Testing
Table 10. Global Mendelian Disorders Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Mendelian Disorders Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Mendelian Disorders Testing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Mendelian Disorders Testing Market Share by Regions (2015-2020)
Table 14. Global Mendelian Disorders Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Mendelian Disorders Testing Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Mendelian Disorders Testing Market Growth Strategy
Table 20. Main Points Interviewed from Key Mendelian Disorders Testing Players
Table 21. Global Mendelian Disorders Testing Revenue by Players (2015-2020) (Million US$)
Table 22. Global Mendelian Disorders Testing Market Share by Players (2015-2020)
Table 23. Global Top Mendelian Disorders Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mendelian Disorders Testing as of 2019)
Table 24. Global Mendelian Disorders Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Mendelian Disorders Testing Product Solution and Service
Table 27. Date of Enter into Mendelian Disorders Testing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 30. Global Mendelian Disorders Testing Market Size Share by Type (2015-2020)
Table 31. Global Mendelian Disorders Testing Revenue Market Share by Type (2021-2026)
Table 32. Global Mendelian Disorders Testing Market Size Share by Application (2015-2020)
Table 33. Global Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 34. Global Mendelian Disorders Testing Market Size Share by Application (2021-2026)
Table 35. North America Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 37. North America Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 38. North America Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 39. North America Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 40. North America Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 41. Europe Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 43. Europe Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 45. Europe Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 47. China Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 48. China Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 49. China Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 50. China Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 51. China Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 52. China Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 53. Japan Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 55. Japan Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 57. Japan Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 61. Southeast Asia Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 63. Southeast Asia Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 65. India Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 66. India Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 67. India Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 68. India Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 69. India Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 70. India Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Mendelian Disorders Testing Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Mendelian Disorders Testing Market Share (2019-2020)
Table 73. Central & South America Mendelian Disorders Testing Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Mendelian Disorders Testing Market Share by Type (2015-2020)
Table 75. Central & South America Mendelian Disorders Testing Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Mendelian Disorders Testing Market Share by Application (2015-2020)
Table 77. Celera Group Company Details
Table 78. Celera Group Business Overview
Table 79. Celera Group Product
Table 80. Celera Group Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 81. Celera Group Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Product
Table 85. Abbott Laboratories Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 86. Abbott Laboratories Recent Development
Table 87. ELITech Group Company Details
Table 88. ELITech Group Business Overview
Table 89. ELITech Group Product
Table 90. ELITech Group Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 91. ELITech Group Recent Development
Table 92. Quest Diagnostics Company Details
Table 93. Quest Diagnostics Business Overview
Table 94. Quest Diagnostics Product
Table 95. Quest Diagnostics Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 96. Quest Diagnostics Recent Development
Table 97. AutoGenomics Company Details
Table 98. AutoGenomics Business Overview
Table 99. AutoGenomics Product
Table 100. AutoGenomics Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 101. AutoGenomics Recent Development
Table 102. PerkinElmer Company Details
Table 103. PerkinElmer Business Overview
Table 104. PerkinElmer Product
Table 105. PerkinElmer Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 106. PerkinElmer Recent Development
Table 107. Roche Diagnostics Company Details
Table 108. Roche Diagnostics Business Overview
Table 109. Roche Diagnostics Product
Table 110. Roche Diagnostics Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 111. Roche Diagnostics Recent Development
Table 112. Bio-Rad Laboratories Business Overview
Table 113. Bio-Rad Laboratories Product
Table 114. Bio-Rad Laboratories Company Details
Table 115. Bio-Rad Laboratories Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 116. Bio-Rad Laboratories Recent Development
Table 117. Applied Biosystems Company Details
Table 118. Applied Biosystems Business Overview
Table 119. Applied Biosystems Product
Table 120. Applied Biosystems Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 121. Applied Biosystems Recent Development
Table 122. Transgenomic Company Details
Table 123. Transgenomic Business Overview
Table 124. Transgenomic Product
Table 125. Transgenomic Revenue in Mendelian Disorders Testing Business (2015-2020) (Million US$)
Table 126. Transgenomic Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mendelian Disorders Testing Market Share by Type: 2020 VS 2026
Figure 2. Carrier Testing Features
Figure 3. Diagnostic Testing Features
Figure 4. New-Born Screening Features
Figure 5. Predictive & Pre-Symptomatic Testing Features
Figure 6. Prenatal Testing Features
Figure 7. Global Mendelian Disorders Testing Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Specialized Clinics Case Studies
Figure 11. Mendelian Disorders Testing Report Years Considered
Figure 12. Global Mendelian Disorders Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Mendelian Disorders Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global Mendelian Disorders Testing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Mendelian Disorders Testing Market Share by Players in 2019
Figure 17. Global Top Mendelian Disorders Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mendelian Disorders Testing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Mendelian Disorders Testing Revenue in 2019
Figure 19. North America Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Mendelian Disorders Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
単遺伝性疾患検査の世界市場（～2026年） According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the co…- 出生前遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prenatal Genetic Testing Scope and Market Size Prenatal Genetic T…
- 出生前検査の世界市場（～2026年） Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. Prenatal screening can detect problems such as neural tube defects, chromosome abnormalities, and it can also detect an…
- 個人ゲノム検査の世界市場（～2026年） Market Analysis and Insights: Global Personal Genome Testing Market The global Personal Genome Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Personal Genome Testing Scope and Market Size Personal Genome Testi…
- 豚診断検査の世界市場（～2026年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …